Zwitterionic chitosan derivatives for pH-sensitive stealth coating

Biomacromolecules

Volumn 11, Issue 9, 2010, Pages 2352-2358

  Xu, Peisheng ^a,b   Bajaj, Gaurav ^a   Shugg, Tyler ^a   Van Alstine, William G ^c   Yeo, Yoon ^a,d  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c PURDUE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDATION; BLOOD COMPONENT; CHARGE PROFILES; CHITOSAN DERIVATIVES; COATING MATERIAL; DRUG CARRIER; INTRAPERITONEAL INJECTIONS; ISO-ELECTRIC POINTS; OPPOSITE CHARGE; PH SENSITIVE; PH-DEPENDENT; PH-RESPONSIVE; PHYSIOLOGICAL PH; PROTEIN ADSORPTION; SUCCINIC ANHYDRIDE;

ADSORPTION; BIOLOGICAL MEMBRANES; CHITOSAN; COATINGS; HYDROGELS; MULTILAYERS; PH EFFECTS; SURFACES;

CHITIN;

AMPHOLYTE; CHITOSAN DERIVATIVE; DRUG CARRIER; SUCCINIC ANHYDRIDE;

AMIDATION; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; DRUG CONJUGATION; DRUG SYNTHESIS; ISOELECTRIC POINT; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN BINDING; RAT;

AMIDES; ANIMALS; CHITOSAN; COMPLEMENT ACTIVATION; HEMOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; INJECTIONS, INTRAPERITONEAL; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED ICR; RATS; RATS, SPRAGUE-DAWLEY; SUCCINIC ANHYDRIDES;

EID: 77956538784     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/bm100481r     Document Type: Article

References (45)

1. Thomas, M.; Klibanov, A. M. Appl. Microbiol. Biotechnol. 2003, 62, 27-34
2. Blau, S.; Jubeh, T. T.; Haupt, S. M.; Rubinstein, A. Crit. Rev. Ther. Drug Carrier Syst. 2000, 17, 425-465
3. Xu, P.; Quick, G. K.; Yeo, Y. Biomaterials 2009, 30, 5834-5843
4. Lee, E. S.; Gao, Z.; Kim, D.; Park, K.; Kwon, I. C.; Bae, Y. H. J. Controlled Release 2008, 129, 228-236
5. Satija, J.; Gupta, U.; Jain, N. K. Crit. Rev. Ther. Drug Carrier Syst. 2007, 24, 257-306
6. Owens, D. E.; Peppas, N. A. Int. J. Pharm. 2006, 307, 93-102
7. Mishra, S.; Webster, P.; Davis, M. E. Eur. J. Cell Biol. 2004, 83, 97-111
8. Gryparis, E. C.; Hatziapostolou, M.; Papadimitriou, E.; Avgoustakis, K. Eur. J. Pharm. Biopharm. 2007, 67, 1-8
9. Romberg, B.; Hennink, W.; Storm, G. Pharm. Res. 2008, 25, 55-71
10. Hong, R. L.; Huang, C. J.; Tseng, Y. L.; Pang, V. F.; Chen, S. T.; Liu, J. J.; Chang, F. H. Clin. Cancer Res. 1999, 5, 3645-3652
11. Kaasgaard, T.; Mouritsen, O. G.; Jørgensen, K. Int. J. Pharm. 2001, 214, 63-65
12. Hatakeyama, H.; Akita, H.; Kogure, K.; Oishi, M.; Nagasaki, Y.; Kihira, Y.; Ueno, M.; Kobayashi, H.; Kikuchi, H.; Harashima, H. Gene Ther. 2007, 14, 68-77
13. Wolf, B. B.; Otto, A. M. A.; Brischwein, M. M.; Kraus, M. M.; Henning, T. T. Anti-Cancer Drugs 2004, 15, 7-14
14. Gerweck, L. E.; Seetharaman, K. Cancer Res. 1996, 56, 1194-1198
15. Montcourrier, P.; Silver, I.; Farnoud, R.; Bird, I.; Rochefort, H. Clin. Exp. Metastasis 1997, 15, 382-392
16. Swallow, C. J.; Grinstein, S.; Rotstein, O. D. J. Biol. Chem. 1990, 265, 7645-7654
17. Sawant, R. M.; Hurley, J. P.; Salmaso, S.; Kale, A.; Tolcheva, E.; Levchenko, T. S.; Torchilin, V. P. Bioconjugate Chem. 2006, 17, 943-949
18. Sethuraman, V.; Lee, M.; Bae, Y. Pharm. Res. 2008, 25, 657-666
19. Lee, E. S.; Na, K.; Bae, Y. H. Nano Lett. 2005, 5, 325-329
20. Sethuraman, V. A.; Bae, Y. H. J. Controlled Release 2007, 118, 216-224
21. Sethuraman, V. A.; Na, K.; Bae, Y. H. Biomacromolecules 2005, 7, 64-70
22. Sharma, G.; Anabousi, S.; Ehrhardt, C.; Kumar, M. J. Drug Targeting 2006, 14, 301-310
23. Kim, D.; Lee, E. S.; Oh, K. T.; Gao, Z. G.; Bae, Y. H. Small 2008, 4, 2043-2050
24. Mohajer, G.; Lee, E. S.; Bae, Y. H. Pharm. Res. 2007, 24, 1618-1627
25. Kim, D.; Gao, Z. G.; Lee, E. S.; Bae, Y. H. Mol. Pharm. 2009, 6, 1353-1362
26. Kim, I.-Y.; Seo, S.-J.; Moon, H.-S.; Yoo, M.-K.; Park, I.-Y.; Kim, B.-C.; Cho, C.-S. Biotechnol. Adv. 2008, 26, 1-21
27. Kato, Y.; Onishi, H.; Machida, Y. Biol. Pharm. Bull. 2000, 23, 1497-1503
28. Kamiyama, K.; Onishi, H.; Machida, Y. Biol. Pharm. Bull. 1999, 22, 179-86
29. Kato, Y.; Onishi, H.; Machida, Y. Biomaterials 2004, 25, 907-915
30. Le-Tien, C.; Millette, M.; Mateescu, M.-A.; Lacroix, M. Biotechnol. Appl. Biochem. 2004, 39, 347-354
31. Yamaguchi, R.; Arai, Y.; Itoh, T.; Hirano, S. Carbohydr. Res. 1981, 88, 172-175
32. Henry, S. M.; El-Sayed, M. E.; Pirie, C. M.; Hoffman, A. S.; Stayton, P. S. Biomacromolecules 2006, 7, 2407-2414
33. Dobrovolskaia, M. A.; Neun, B. W. NCL Method ITA-5: Qualitative Analysis of Total Complement Activation by Western Blot; National Cancer Institute at Frederick: Frederick, MD, 2005.
34. Vanichvattanadecha, C.; Supaphol, P.; Nagasawa, N.; Tamada, M.; Tokura, S.; Furuike, T.; Tamura, H.; Rujiravanit, R. Polym. Degrad. Stab. 2010, 95, 234-244
35. Quinteros, D. A.; Rigo, V. R.; Kairuz, A. F. J.; Olivera, M. E.; Manzo, R. H.; Allemandi, D. A. Eur. J. Pharm. Sci. 2008, 33, 72-79
36. Wallach, J. B. Interpretation of Diagnostic Tests, 7th ed.; Lippincott Williams & Wilkins: Philadelphia, PA, 2000.
37. Godbey, W. T.; Wu, K. K.; Mikos, A. G. J. Biomed. Mater. Res. 1999, 45, 268-275
38. Huebsch, N. D.; Mooney, D. J. Biomaterials 2007, 28, 2424-37
39. Ishihara, M.; Nakanishi, K.; Ono, K.; Sato, M.; Kikuchi, M.; Saito, Y.; Yura, H.; Matsui, T.; Hattori, H.; Uenoyama, M.; Kurita, A. Biomaterials 2002, 23, 833-840
40. Roy, K.; Mao, H.-Q.; Huang, S.-K.; Leong, K. W. Nature Med. 1999, 5, 387-391
41. Agrawal, P.; Strijkers, G. J.; Nicolay, K. Adv. Drug Deliv. Rev. 2010, 62, 42-58
42. Baldrick, P. Regul. Toxicol. Pharmacol. 2010, 56, 290-299
43. Minami, S.; Suzuki, H.; Okamoto, Y.; Fujinaga, T.; Shigemasa, Y. Carbohydr. Polym. 1998, 36, 151-155
44. Yeo, Y.; Burdick, J. A.; Highley, C. B.; Marini, R.; Langer, R.; Kohane, D. S. J. Biomed. Mater. Res. 2006, 78A, 668-675
45. Kohane, D. S.; Tse, J. Y.; Yeo, Y.; Padera, R.; Shubina, M.; Langer, R. J. Biomed. Mater. Res. 2006, 77A, 351-361